ARTICLE | Company News
Apricus Biosciences, Takeda sales and marketing update
September 24, 2012 7:00 AM UTC
Apricus' NexMed Inc. subsidiary granted Takeda an exclusive license to commercialize Vitaros alprostadil in the U.K. NexMed will receive an undisclosed upfront payment and is eligible for up to €35 ...